Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?

Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?

The appropriate immunosuppressive regimen in kidney transplant recipients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2/COVID-19) infection remains unclear. The impact of direct virus injury complicated by dysregulated hyperimmune response with overwhelming release of various cyto...

Full description

Bibliographic Details
Main Authors: Ahmed Daoud, Ahmad Alqassieh, Duaa Alkhader, Maria Aurora Posadas Salas, Vinaya Rao, Tibor Fülöp, Karim M. Soliman
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Renal Failure
Subjects:
covid-19; kidney transplant; bamlanivimab; immunosuppression; ivermectin; cni.
Online Access:http://dx.doi.org/10.1080/0886022X.2021.1876730

Internet

http://dx.doi.org/10.1080/0886022X.2021.1876730

Similar Items